EP1084229A1 - Herstellung von primmorphen aus dissoziierten zellen von schwämmen, korallen und weiteren invertebraten und deren verwendung - Google Patents
Herstellung von primmorphen aus dissoziierten zellen von schwämmen, korallen und weiteren invertebraten und deren verwendungInfo
- Publication number
- EP1084229A1 EP1084229A1 EP99955288A EP99955288A EP1084229A1 EP 1084229 A1 EP1084229 A1 EP 1084229A1 EP 99955288 A EP99955288 A EP 99955288A EP 99955288 A EP99955288 A EP 99955288A EP 1084229 A1 EP1084229 A1 EP 1084229A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- primmorphs
- cells
- aggregates
- cell
- substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000014653 Carica parviflora Nutrition 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 241000242757 Anthozoa Species 0.000 title claims description 14
- 108010017842 Telomerase Proteins 0.000 claims abstract description 35
- 239000000126 substance Substances 0.000 claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 30
- 230000006820 DNA synthesis Effects 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000000338 in vitro Methods 0.000 claims abstract description 15
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- 244000005700 microbiome Species 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 188
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 claims description 43
- 239000013535 sea water Substances 0.000 claims description 24
- 239000006285 cell suspension Substances 0.000 claims description 19
- 230000015572 biosynthetic process Effects 0.000 claims description 17
- 210000001519 tissue Anatomy 0.000 claims description 16
- 239000012984 antibiotic solution Substances 0.000 claims description 13
- 238000011534 incubation Methods 0.000 claims description 13
- 230000035755 proliferation Effects 0.000 claims description 12
- 230000000975 bioactive effect Effects 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 230000004663 cell proliferation Effects 0.000 claims description 8
- 238000010494 dissociation reaction Methods 0.000 claims description 8
- 230000005593 dissociations Effects 0.000 claims description 8
- 238000009360 aquaculture Methods 0.000 claims description 7
- 244000144974 aquaculture Species 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000003102 growth factor Substances 0.000 claims description 6
- 238000010348 incorporation Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004677 Nylon Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000007613 environmental effect Effects 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 230000002062 proliferating effect Effects 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 102000006495 integrins Human genes 0.000 claims description 2
- 108010044426 integrins Proteins 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims 3
- 238000012364 cultivation method Methods 0.000 claims 3
- 239000012228 culture supernatant Substances 0.000 claims 2
- 235000003170 nutritional factors Nutrition 0.000 claims 2
- 210000003463 organelle Anatomy 0.000 claims 2
- -1 organelles Substances 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 230000000340 anti-metabolite Effects 0.000 claims 1
- 229940100197 antimetabolite Drugs 0.000 claims 1
- 239000002256 antimetabolite Substances 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 229960001484 edetic acid Drugs 0.000 claims 1
- 231100000317 environmental toxin Toxicity 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 241000243321 Cnidaria Species 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 2
- 230000001488 breeding effect Effects 0.000 abstract description 2
- 235000006180 nutrition needs Nutrition 0.000 abstract description 2
- 241000243142 Porifera Species 0.000 description 50
- 241000544639 Suberites domuncula Species 0.000 description 25
- 238000004458 analytical method Methods 0.000 description 7
- 238000002372 labelling Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 241001356229 Dendronephthya hemprichi Species 0.000 description 6
- 229910052793 cadmium Inorganic materials 0.000 description 6
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 6
- 230000002949 hemolytic effect Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000243124 Geodia cydonium Species 0.000 description 4
- 108700023238 Suberites domuncula suberitine Proteins 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 229930193760 suberitine Natural products 0.000 description 4
- 241000124001 Alcyonacea Species 0.000 description 3
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 230000012292 cell migration Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 3
- 239000002644 phorbol ester Substances 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- QGVLYPPODPLXMB-UBTYZVCOSA-N (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(O)C(C)(C)[C@H]3[C@@H]21 QGVLYPPODPLXMB-UBTYZVCOSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102000003923 Protein Kinase C Human genes 0.000 description 2
- 108090000315 Protein Kinase C Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- QGVLYPPODPLXMB-QXYKVGAMSA-N phorbol Natural products C[C@@H]1[C@@H](O)[C@]2(O)[C@H]([C@H]3C=C(CO)C[C@@]4(O)[C@H](C=C(C)C4=O)[C@@]13O)C2(C)C QGVLYPPODPLXMB-QXYKVGAMSA-N 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
- AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241000243143 Demospongiae Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000272184 Falconiformes Species 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000498174 Hymeniacidon heliophila Species 0.000 description 1
- 241000485279 Latrunculia Species 0.000 description 1
- 101000653787 Mus musculus Protein S100-A11 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000242752 Octocorallia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 235000013290 Sagittaria latifolia Nutrition 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 239000008051 TBE buffer Substances 0.000 description 1
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 108010015046 cell aggregation factors Proteins 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015246 common arrowhead Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004029 environmental poison Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
Definitions
- This invention relates to the establishment of the first and thus a new method for the cultivation of sponge cells, coral cells and cells of other invertebrates in vitro.
- the cells cultured in vitro which can be cultured as aggregate-like units, are called primmorphs.
- This is a method that makes it possible for the first time to introduce processes with cells / aggregates / primmorphs from sponges, corals and other invertebrates: (i) for the production of proliferation and DNA synthesis modulating substances, (ii) for identification / Detection of environmentally harmful substances, (iii) for the cultivation of bacteria and other microorganisms, (iv) for the production of asexual reproductive bodies, which can be used in aquaculture to grow out into corresponding organisms, (v) for the creation of cell banks, (vi) for the optimization of the Nutritional needs of the cells / aggregates / primmorphs, and (vii) to identify substances that modulate telomerase activity in cells / aggregates / primmorphs.
- the Phylum Porifera (sponges) has a monophyletic origin with the other Metazoen-Phyla [Müller WEG (1995) Naturwissenschaften 82, 321-329].
- a basic autapomorphic feature of the Metazoa, including the Porifera, is, for example, the presence of the receptor tyrosine kinase, which can only be found in Metazoa [Müller WEG, Schcke H (1996) Prog Molec Subcell Biol 17, 183-208].
- the Porifera show a plesiomorphic feature that cannot be found in any other higher Metazoan phylum; all (or almost all) of their cells have high levels of telomerase activity [Koziol C, Borojevic R, Steffen R, Müller WEG (1998) Mech Aging Develop 100, 107-120]. In principle, this indicates that sponge cells cannot be divided into germ or somatic cells [Müller WEG (1998a) Progr Molec Subcell Biol 19, 98-132; Müller WEG (1998b) Naturwiss 85: 11-25]. In higher non-cancer patients Metazoa are almost always the germ cells telomerase-positive, while the somatic cells are telomerase-negative [Lange T v (1998) Science 279, 334-335].
- Dendronephthya hemprichi (Cnidaria, Anthozoa, Alcyonaria) acquired from a pet store and - with the exception of temperature (22 ° C) - kept like sponges.
- the remaining pieces of tissue are again mixed with new CMFSW-E in the same ratio and again shaken gently rotating.
- the supernatant is decanted and discarded.
- the tissue pieces are now mixed with new CMFSW-E and moved on a shaker for usually 40 minutes.
- the supernatant, which contains the cells, is through a nylon mesh, mesh size z. B. 40 microns, filtered and collected in a tube. This operation, shaking the tissue Pieces in CMFSW-E and filtration of the supernatant through a nylon mesh is repeated several times.
- the combined cell suspensions are gently centrifuged to obtain the cells [usually at 500xg for 5 min].
- the Zeil suspension is taken up in seawater / antibiotic solution [antibiotics: usually 100 IU penicillin and 100 ⁇ g / ml streptomycin]. This process is usually repeated one or more times.
- the collected cells are obtained by centrifugation. A cell suspension of 10? Cells / ml is adjusted and 1 ml thereof is usually added to 5 ml sea water / antibiotic solution in a z. B. 60 mm petri dish [e.g. B. Falcon catalog number 3004].
- the cells are incubated, usually at 16 ° C, and are usually transferred four times to a new Petri dish by careful resuspension with seawater / antibiotic solution. This is also to ensure that the cells do not stick to the shell.
- New aggregates can be obtained from the mother petri dish several times, usually two to five times.
- the washed aggregates remain in the Petri dishes until they have a smooth surface.
- the seawater / antibiotic solution is usually renewed every day; two thirds of the solution are replaced by fresh sea water / antibiotic solution.
- the incorporation of BrdU [5-bromo-2'-deoxy-uridine] into the cellular DNA was measured using the "BrdU labeling and detection kit", according to the manufacturer's instructions.
- the primmorphs are usually in 1 ml
- the cells are then incubated with anti-BrdU mouse monoclonal antibodies and the immune complex is made visible with anti-mouse Ig / coupled with alkaline phosphatase and with the color substrate nitro blue tetrazolium salt.
- the cells are analyzed by light microscopy.
- the primmorphs are fixed in 4% paraformaldehyde / phosphate-buffered saline [Romeis, B. (1989) Microscopic Technology. Kunststoff; Urban and Schwarzenberg]. After dehydration with ethanol, the primmorphs are embedded in Technovit 8100 [Beckstead J H (1985) J Histochem Cytochem 9, 954-958]. Sections with a thickness of 2 ⁇ m are made and stained with Ziehl's Fuchsin solution [Martoja R, Martoja M (1967) Initiation aux Techniques de THistologie Animale. Prem. Ed. Masson et Cie, Paris].
- Telomerase activity is detected using the polymerase chain reaction [PCR] method using the "Telomerase Detection Kit (TRAPeze)"; Details have been described earlier [Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Science 266: 2011-2014; Koziol C, Borojevic R, Steffen R, Müller WEG (1998) Mech Aging Develop 100, 107-120]. The cell extracts added correspond to 5 x 10 3 cell equivalents.
- the amplification products are quantified by electrophoresis using a 12.5% non-denaturing polyacrylamide gel in 0.5 x TBE buffer [performed according to the manufacturer's instructions].
- the gels are stained with SYBR Green I in order to recognize DNA fragments [Molecular Probes (1996) MP 7567 07/16/96].
- the signals are recorded with a GS-525 Molecular Imager (bio Wheel) quantified.
- the degree of telomerase activity is given in TPG (total product generated) and is calculated as described [Oncor (1996) TRAPeze telomerase detection kit; catalog no. S7700 kit; second edition. Oncor, Gaithersburg, MD; UNITED STATES].
- Specimens of the S. domuncula sea sponge were used to isolate the cells (Fig. 1A). Single cells were obtained by dissociation as described above. After the specified washing steps, the protozoa that preferentially adhere to the surface of the plastic culture vessels are removed. The cells are transferred to a seawater / antibiotic solution. After the entire treatment / incubation period of usually five days, primmorphs (Fig. 1 D) form from the cell aggregates (Fig. 1 B and C). After an incubation period of two days, the diameter of the cell aggregates is approximately 100 ⁇ m (Fig. 1B) and increases in size continuously; after four days a diameter of usually 300 ⁇ m is reached (Fig. 1 C). During this time, the aggregates are rounded off. Usually, primmorphs about 1 to 2 mm in size form after another three to five days (Fig. 1 D).
- the cells that form the squamous epithelium of the primmorphs are pinacocytes, as can be deduced from their flattened fusiform runners and their clear nuclei [Review: Simpson TL (1984) The Cell Biology of Sponges. Springer Verlag, New York]; the size of the cells fluctuates around 20-30 ⁇ m.
- the cells within the primmorphs are mainly spherical cells. They have a diameter of approximately 30 to 40 ⁇ m and are characterized by large round vacuoles, which occupy the majority of the cells.
- the other cells can be called amoebocytes and archaeocytes and have a size of about 40 ⁇ m.
- the outer appearance of the primmorphs is smooth and almost spherical (Fig. 1 D); the histological sections show that the cells in the primmorphs are well organized into a tissue-like body (Fig. 1 E and F). It is striking that the squamous epithelium is formed from a multicellular layer of mostly pinacocytes (Fig. 1 F), which cannot be found in natural sponges; these are limited by a unicellular epithelium.
- the organized arrangement of the cells within the primmorphs also distinguishes them from the aggregates which are formed from dissociated cells in the presence of the homoigenic aggregation factor [Müller WEG (1982) Intern Rev Cytol 77, 129-181].
- the primmorphs described here are formed from a single cell suspension in vitro. As shown here, the dissociated cells form tissue-like bodies.
- the construction of functional primmorphs from a single cell suspension implies that this formation is an active process that involves the removal of dead cells and cell fragments; when viewed microscopically, this can be seen as "frayed" edges of the primmorphs.
- the formation of a squamous epithelium from pinacocytes further indicates that sponge cells differentiate and then re-differentiate into cells that are necessary for the formation of primmorphs.
- the primmorphs obtained from S. domuncula have been kept in culture for over five months. These primary primmorphs can be dissociated into single cells again in CMFSW-E. The resulting single cell suspension is still able to form aggregates and then primmorphs, which are now called secondary primmorphs. This process occurs when the cells are transferred to sea water / antibiotic solution.
- the kinetics of primmorph formation is usually identical to that observed for primary primmorphs.
- the cells from primary primmorphs adhere weakly to the surface of the culture vessels after dissociation [e.g. B. Falcon catalog number 3004].
- the tubes must be roughened slightly with a cover glass or a rubber scraper.
- the level of telomerase activity was determined in the cells during the formation of primmorphs from a single cell suspension.
- the results show that cells in the natural cell structure have a high telomerase activity; a quantitative analysis showed an activity of 8.9 TPG units / 5 x 10 3 line equivalents (Fig. 2; lane a). If the telomerase activity was determined in cells which were left in the dissociated single-cell state for 14 hours, the enzyme level dropped to 0.9 TPG units / 5 ⁇ 10 3 cell equivalents (FIG. 2; lane b). However, when cells from primmorphs [about 10 days after formation from single cells] were used for the analysis, a telomerase activity of 4.7 TPG units / 5 ⁇ 10 3 cells resulted (FIG. 2; lane c).
- the BrdU label and the "Detection" approach were used to show that those cells that had organized themselves into primmorphs regain their proliferation ability.
- the cells were incubated with BrdU for 12 hours determined by BrdU in the DNA and quantified with the aid of an anti-BrdU monoclonal antibody as described above Cells which have incorporated BrdU in the DNA are distinguished by a dark (dark brown) colored cell nucleus (FIGS. 3B-D). Controls that were not incubated with the primary antibody against BrdU are not stained (Fig. 3A).
- Fig. 4 The analysis of tissue samples after extraction of the RNA and subsequent separation in the agarose gel shows that in addition to the two host rRNAs, 28S and 18S rRNA, prokaryotic rRNAs, 23S and 16S rRNA also occur in S. domuncula (Fig. 4; Lane a). After dissociation and subsequent production of primmorphs in culture, the prokaryotic rRNAs, 23S and 16S rRNA, are usually also detected (Fig. 4; lane b). This shows that primmorphs can also contain microorganisms without "contaminating the culture".
- the percentage of BrdU-positive cells as well as two-nucleus stages is given for each batch series.
- the analysis was performed with: (i) dissociated cells kept in CMFSW-E for 1 day, (ii) cell aggregates from single cell suspension after 1 day in culture in sea water, (iii) primary primmorphs [formation after 10 days ] and (iv) secondary primmorphs [formed from one month old primary primmorphs after dissociation in single cells and subsequent formation of secondary primmorphs]. 300 cells were counted per batch.
- the primary primmorphs were obtained from single cells of S. domuncula and used for the experiments after 21 days. 4.1. Identification of DNA synthesis modulating and proliferation modulating substances using primmorphs
- the primmorphs were incubated for two days with different concentrations of PMA.
- the DNA synthesis was then determined using BrdU labeling as described above.
- the control percentage of BrdU positive cells in primmorphs without test substance, was set as 100%.
- the results which are summarized in Fig. 5, show that in the concentration range from 0.01 to 1 ⁇ g PMA / ml there is a marked percentage increase in BrdU-positive cells in primmorphs (Fig. 5). Based on this data, it can be concluded that primmorphs are excellent
- Organisms can be assumed that the system of the primmorphs is a sensitive one
- the bioactive substances of primmorphs are produced in small (1 ml) or larger (20 l) quantities; it can also take place in larger bioreactors and also in aquaculture.
- the cells that are apoptotically killed by heat shock (which serve as a source of nutrients) expose phosphatidylserine and phosphatidylinositol and other lipids on their cell surface. These apoptotically modified cells / membranes are phagocited by the primmorphs.
- Tumor cells are known to have high telomerase activity [Hastie ND, Dempster M, Dunlop AG, Thompson AM, Green DK, Allshire RC (1990) Nature 346, 866-868].
- One goal of medical research is to reduce the activity of this enzyme in tumor cells. Due to the fact that sponge cells are telomerase-positive, the model of the primmorphs is therefore extremely suitable for testing substances that reduce this activity.
- telomerase activity can be modulated in cells of primmorphs.
- telomerase activity in cells of S. domuncula after adding antibody (rabbit - polyclonal) to primmorphs. 50 ⁇ l of antibody per well were added to the batches. The telomerase activity is given in TPG (total product generated) and standardized to 5 x 10 3 cell equivalents.
- Primmorphs can be used for the cultivation of larger tissue cultures and for the cultivation of entire corresponding organisms. Aquaculture is used for this. Primmorphs are usually incubated in z. B. "culture chamber slides" [(Nunc) - catalog number 177453] with these into larger artificial containers (such as aquariums), or directly into nature (aquatic environment). If larger artificial containers (such as aquariums) are used, as in the case of S. domuncula, these are filled with artificial sea water and mixed with the usual trace minerals. Usually once a week the medium is some organic material, such as. B. tuna added. After an average of one month, the primmorphs have grown to 5 mm large organism-like structures. Longer incubation times lead to further growth until the finished organism.
- cells either immediately after dissociation from the parent organism, e.g. B. the sponge S. domuncula, or obtained from primmorphs and frozen.
- the cells are slowly frozen (usually 1 ° C./min) in a suitable tube, usually in dimethyl sulfoxide (usually 10% in sea water) or glycerol (usually 20% in sea water).
- the cell number is adjusted to approximately 5 x 10 6 cells / ml.
- the cells are then transferred to liquid nitrogen and can be stored for over six months. If the cells are thawed again, they can be opened in stages
- Invertebrates can be frozen. This also gives you the option of sending cells in the usual way (e.g. in dry ice). This means that cells can be cultivated at a central location, i.e. cell banks can be established.
- FIGURES Fig. 1 Formation of primmorphs from cells of the Suberites domuncula sponge.
- A. a specimen of S. domuncula; Magnification x 1.
- the cells are dissociated by treatment in CMFSW-E. After two days in culture, cell aggregates [medium: seawater / antibiotics] B form, which increase in size [uptake after three to four days] C; x 10.
- Primmorphs D usually form after five days; x 10.
- E and F cross-sections through a primmorph, show the multi-cell epithelium-like location of pinacocytes that surrounds the inner part, which consists of spherical cells, amoebocytes and archaeocytes; E: x 20; F: x 45.
- Fig. 2 Telomerase activity in cells of S. domuncula. Telomerase activity was determined (i) in cells of tissue (lane a), (ii) in single cell suspension [the cells were analyzed for 14 hours] (lane b) and (in) in primmorphs (lane c). Defined amounts of material, corresponding to 5 x 10 3 line equivalents, were created incubated in the TRAP approach. After PCR amplification, the products were separated in a non-denaturing polyacrylamide gel; the gel was stained with SYBR Green I to make the DNA fragment visible.
- Fig. 3 Cells from primmorphs with the aim of detecting DNA synthesis there.
- the primmorphs were incubated in BrdU (details in the text); BrdU is incorporated into the DNA - if DNA synthesis has taken place.
- the built-in BrdU units are detected by an antibody reaction using the "BrdU labeling and detection kit". These appear as dark spots that mark the core of the line.
- B - D cells from primmorphs which were incubated with BrdU and then treated with the identification reagent to detect BrdU.
- Fig. 3D shows a BrdU-positive cell, indicated by an arrow; a BrdU-negative cell is marked by an arrow head.
- Fig. 4 Analysis of tissue samples and primmorphs on rRNA. The material was extracted and the RNA was then separated in the agarose gel. In addition to the two eucaryotic host rRNAs [euc], 28S and 16S rRNA, procaryotic rRNAs [proc], 23S and 16S rRNA are also visualized by ethidium bromide.
- Fig. 5 Influence of the phorbol ester Phorbol 12-myristat 13-acetate (PMA) on the percentage of BrdU-positive cells in primmorphs of S. domuncula. The primmorphs were incubated with different concentrations of PMA for two days. The DNA synthesis was then determined using BrdU labeling. The control, percentage of BrdU-positive cells in primmorphs without test substance, was set to 100%. 300 cells were counted per batch.
- PMA phorbol ester Phorbol 12-myristat 13-acetate
- Fig. 6 Influence of cadmium, concentrations between 0.1 ng / ml and 100 ng / ml were selected, on the level of the percentage of BrdU-positive cells in primmorphs.
- Fig. 7 Production of suberitine, a toxic protein, in primmorphs from S. domuncula. Primmorphs were cultivated. After 0 [transfer of the primmorphs into the 24-hole plates] to 20 days, primmorphs were removed and tested for bioactivity. For each incubation point five parallel batches of primmorphs were taken, a crude extract was prepared and tested for hemolytic activity. The titer, expressed in UU (hemolytic units), is based on 1 mg protein extract. The mean values with the standard deviations are given. * (P ⁇ 0.001).
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19824384A DE19824384B4 (de) | 1998-05-30 | 1998-05-30 | Herstellung von Primmorphen aus dissoziierten Zellen von Schwämmen und Korallen, Verfahren zur Kultivierung von Zellen von Schwämmen und Korallen zur Produktion und Detektion von bioaktiven Substanzen, zur Detektion von Umweltgiften und zur Kultivierung dieser Tiere in Aquarien und im Freiland |
DE19824384 | 1998-05-30 | ||
PCT/EP1999/003121 WO1999063060A1 (de) | 1998-05-30 | 1999-05-06 | Herstellung von primmorphen aus dissoziierten zellen von schwämmen, korallen und weiteren invertebraten und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1084229A1 true EP1084229A1 (de) | 2001-03-21 |
Family
ID=7869507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99955288A Withdrawn EP1084229A1 (de) | 1998-05-30 | 1999-05-06 | Herstellung von primmorphen aus dissoziierten zellen von schwämmen, korallen und weiteren invertebraten und deren verwendung |
Country Status (9)
Country | Link |
---|---|
US (1) | US6664106B1 (ja) |
EP (1) | EP1084229A1 (ja) |
JP (1) | JP2002517188A (ja) |
AU (1) | AU754250B2 (ja) |
CA (1) | CA2332968A1 (ja) |
DE (1) | DE19824384B4 (ja) |
NO (1) | NO20006051L (ja) |
NZ (1) | NZ508602A (ja) |
WO (1) | WO1999063060A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2261054B1 (es) * | 2004-12-31 | 2007-11-16 | Universidad De Almeria | Procedimiento para obtener un extracto de pulpo, el producto obtenido y su aplicacion como suplemento para el cultivo y criopreservacion de tejido y de celulas en suspension de invertebrados marinos. |
US20110179504A1 (en) * | 2007-09-17 | 2011-07-21 | Ramot at Tel-Aviv Univeristy Ltd. | Method For Coral Tissue Cultivation And Propagation |
RU2472516C1 (ru) * | 2011-06-16 | 2013-01-20 | Общество с ограниченной ответственностью "АйБИОСТ" | Биоматериал для замещения костных дефектов |
CN102630646B (zh) * | 2012-04-24 | 2013-07-17 | 海南大学 | 一种枝状珊瑚人工感染法 |
WO2016117949A1 (ko) | 2015-01-21 | 2016-07-28 | (의료)길의료재단 | 포스파티딜이노시톨포스페이트 결합 물질의 세포 사멸 검출 용도 |
CN105076115A (zh) * | 2015-08-31 | 2015-11-25 | 厦门大学 | 海绵细胞团冷冻保存液及其保存方法 |
CN108651443A (zh) * | 2016-01-04 | 2018-10-16 | 潘时辉 | 一种白血病治疗用的细胞冻存液 |
CN107027742B (zh) * | 2016-01-05 | 2019-01-18 | 河北生命原点生物科技有限公司 | 一种用于白血病治疗的细胞冻存液 |
FR3109584B1 (fr) * | 2020-04-27 | 2024-05-10 | Paulou Massat Sophie De | Microcompartiment pour la culture de cellules de cnidaires |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3230527A1 (de) * | 1982-08-17 | 1984-02-23 | A. Nattermann & Cie GmbH, 5000 Köln | Screening methode |
-
1998
- 1998-05-30 DE DE19824384A patent/DE19824384B4/de not_active Expired - Fee Related
-
1999
- 1999-05-06 JP JP2000552256A patent/JP2002517188A/ja active Pending
- 1999-05-06 NZ NZ508602A patent/NZ508602A/xx unknown
- 1999-05-06 EP EP99955288A patent/EP1084229A1/de not_active Withdrawn
- 1999-05-06 WO PCT/EP1999/003121 patent/WO1999063060A1/de not_active Application Discontinuation
- 1999-05-06 CA CA002332968A patent/CA2332968A1/en not_active Abandoned
- 1999-05-06 US US09/701,974 patent/US6664106B1/en not_active Expired - Fee Related
- 1999-05-06 AU AU42585/99A patent/AU754250B2/en not_active Ceased
-
2000
- 2000-11-29 NO NO20006051A patent/NO20006051L/no not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO9963060A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999063060A1 (de) | 1999-12-09 |
NZ508602A (en) | 2002-10-25 |
CA2332968A1 (en) | 1999-12-09 |
NO20006051L (no) | 2001-01-30 |
US6664106B1 (en) | 2003-12-16 |
AU754250B2 (en) | 2002-11-07 |
JP2002517188A (ja) | 2002-06-18 |
DE19824384B4 (de) | 2006-03-30 |
AU4258599A (en) | 1999-12-20 |
DE19824384A1 (de) | 1999-12-02 |
NO20006051D0 (no) | 2000-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Borisenko et al. | Transdifferentiation is a driving force of regeneration in Halisarca dujardini (Demospongiae, Porifera) | |
Bergquist | Sponges | |
DE2651685A1 (de) | Verfahren zur serienmaessigen zuechtung von keratinozyten | |
Lavrov et al. | Sponge cell reaggregation: mechanisms and dynamics of the process | |
Ereskovsky et al. | Ultrastructural description of development and cell composition of primmorphs in the endemic Baikal sponge Lubomirskia baicalensis | |
DE19824384B4 (de) | Herstellung von Primmorphen aus dissoziierten Zellen von Schwämmen und Korallen, Verfahren zur Kultivierung von Zellen von Schwämmen und Korallen zur Produktion und Detektion von bioaktiven Substanzen, zur Detektion von Umweltgiften und zur Kultivierung dieser Tiere in Aquarien und im Freiland | |
DE2314076B2 (de) | Verfahren zur Herstellung von karzinoembyonischem Antigen | |
CH629533A5 (de) | Verfahren zur gewinnung von insulin mittels genetisch umgebildeter funguszellen. | |
DE102015222279A1 (de) | Dreidimensionales Zellkulturmodell der Schweißdrüse, insbesondere der humanen Schweißdrüse | |
Nickel et al. | Comparative studies on two potential methods for the biotechnological production of sponge biomass | |
EP1636350B1 (de) | Verfahren zur differenzierung von stammzellen in zellen, die ein pankreatisches hormon produzieren | |
Gantt | Handbook of Phycological Methods: Developmental and cytological methods, edited by E. Gantt | |
CN107858322B (zh) | 一种海马原代细胞培养体系的建立方法 | |
EP2677027A1 (de) | Verfahren zur Herstellung von funktionalem Fusionsgewebe aus humanen Chondrozyten | |
Kahn et al. | The role of non-acid-fast rods and granules in the developmental cycle of the tubercle bacillus | |
Wyeth et al. | Use of sandwich cultures for the study of feeding in the hexactinellid sponge Rhabdocalyptus dawsoni (Lambe, 1892) | |
RU2370458C2 (ru) | Способ борьбы с "цветением" воды синезелеными водорослями | |
Thorington et al. | Transmission of symbionts through the sexual cycle of Hydra viridis. I. Observations on living organisms | |
DE69723264T2 (de) | Verfahren und medium zur zellzüchtung, so erhaltene zellzusammensetzung und ihre anwendungen als produktionssystem und als forschungsmodell | |
DE102004017484A1 (de) | Verfahren zur Herstellung einer biologischen Materialzusammensetzung tierischen Ursprungs | |
Thorington et al. | Transmission of the algal and bacterial symbionts of green hydra through the host sexual cycle | |
Linley | Nutrient agar mixtures for culture of food organisms for predaceous Culicoides larvae (Diptera: Ceratopogonidae) | |
DE102004025080B4 (de) | Multizelluläre Testsysteme | |
Rybak et al. | Analysis of the type material of Gomphosphenia tackei (Bacillariophyceae) and comparison to epizoic diatom populations on freshwater snails | |
Kelley et al. | Ultrastructure of Gloeodinium Montanum (DINOPHYCEAE) 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001219 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): CY DE DK ES FI FR GB GR IE IT NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20040108 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20070904 |